title: Protein kinase C zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent mechanism.
abstract: Pancreatic cancer is a very aggressive disease with few therapeutic options. In this study, we investigate the role of protein kinase C zeta (PKCζ) in pancreatic cancer cells. PKCζ has been shown to act as either a tumor suppressor or tumor promoter depending upon the cellular context. We find that PKCζ expression is either maintained or elevated in primary human pancreatic tumors, but is never lost, consistent with PKCζ playing a promotive role in the pancreatic cancer phenotype. Genetic inhibition of PKCζ reduced adherent growth, cell survival and anchorage-independent growth of human pancreatic cancer cells in vitro. Furthermore, PKCζ inhibition reduced orthotopic tumor size in vivo by inhibiting tumor cell proliferation and increasing tumor necrosis. In addition, PKCζ inhibition reduced tumor metastases in vivo, and caused a corresponding reduction in pancreatic cancer cell invasion in vitro. Signal transducer and activator of transcription 3 (STAT3) is often constitutively active in pancreatic cancer, and plays an important role in pancreatic cancer cell survival and metastasis. Interestingly, inhibition of PKCζ significantly reduced constitutive STAT3 activation in pancreatic cancer cells in vitro and in vivo. Pharmacologic inhibition of STAT3 mimicked the phenotype of PKCζ inhibition, and expression of a constitutively active STAT3 construct rescued the transformed phenotype in PKCζ-deficient cells. We conclude that PKCζ is required for pancreatic cancer cell transformed growth and invasion in vitro and tumorigenesis in vivo, and that STAT3 is an important downstream mediator of the pro-carcinogenic effects of PKCζ in pancreatic cancer cells.
authors.affiliation: Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida, United States of America.
authors.forename: Amanda M
authors.initials: AM
authors.lastname: Butler
authors.forename: Michele L
authors.initials: ML
authors.lastname: Scotti Buzhardt
authors.forename: Shuhua
authors.initials: S
authors.lastname: Li
authors.forename: Kristin E
authors.initials: KE
authors.lastname: Smith
authors.forename: Alan P
authors.initials: AP
authors.lastname: Fields
authors.forename: Nicole R
authors.initials: NR
authors.lastname: Murray
mesh_terms: D000230:Adenocarcinoma / Q000201:enzymology* / Q000473:pathology; D000818:Animals; D045744:Cell Line, Tumor; D002470:Cell Survival; D055785:Gene Knockdown Techniques; D006801:Humans; D008297:Male; D051379:Mice; D008819:Mice, Nude; D009361:Neoplasm Invasiveness; D009368:Neoplasm Transplantation; D010190:Pancreatic Neoplasms / Q000201:enzymology* / Q000473:pathology; D010641:Phenotype; D010766:Phosphorylation; D011493:Protein Kinase C / Q000502:physiology*; D011499:Protein Processing, Post-Translational; D034741:RNA, Small Interfering / Q000235:genetics; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D047368:Tumor Burden; D000099221:Protein Kinase C zeta
chemical_list: D011493:Protein Kinase C; D034741:RNA, Small Interfering; D050796:STAT3 Transcription Factor; D000099221:Protein Kinase C zeta; C494086:STAT3 protein, human